NBD AI Bulletin- BGI Genomics Co, Ltd (SZ 300676, close price: 132.5 yuan) on November 12 announced that recently received a notice from Shenzhen Qianhai BGI Investment, saying that the latter has reduced its holdings by about 11.49 million shares, equivalent to 3 percent stake, through centralized bidding and block transactions, from June 11, 2020 to November 10, 2020.
The 2019 annual report shows that BGI Genomics Co, LTD's main business is the genomics application industry, accounting for 99.76% of the revenue.
(By Gao Han)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.